+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Cardiovascular Implants Market - Global Forecast 2026-2032- Product Image
Cardiovascular Implants Market - Global Forecast 2026-2032- Product Image
New

Cardiovascular Implants Market - Global Forecast 2026-2032

  • PDF Icon

    Report

  • 181 Pages
  • January 2026
  • Region: Global
  • 360iResearch™
  • ID: 6010720
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The cardiovascular implants market is undergoing significant transformation, fueled by continuous innovations, evolving clinical requirements, and complex regulatory landscapes. For senior decision-makers, understanding this market’s direction is essential for informed strategy, supply chain resilience, and long-term growth.

Market Snapshot: Cardiovascular Implants Market Growth

Between 2025 and 2026, the cardiovascular implants market expanded from USD 37.60 billion to USD 39.78 billion. Sustained momentum is projected, with an annual growth rate of 6.37%, resulting in a market value of USD 57.98 billion by 2032. This surge highlights continued demand for advanced cardiovascular therapies, technology-driven product advancements, and dynamic reimbursement models. Tracking the cardiovascular implants market is crucial for aligning business strategies with global healthcare trends and identifying competitive opportunities.

Scope & Segmentation

  • Product Types: Heart valves, stents, implantable cardioverter defibrillators, pacemakers, occluders, and vascular grafts comprise the segment, including variations such as mechanical and tissue valves, diverse tissue origins, and stents organized by drug type.
  • Material Types: Biological tissue, metals, and polymers each add distinct attributes to device biocompatibility, strength, and longevity, directly impacting patient-specific outcomes and clinical adoption.
  • Technology Categories: Bare metal, bioabsorbable, and drug-eluting solutions differentiate devices by their therapeutic approaches and deployment characteristics in practice.
  • Procedural Approaches: Minimally invasive and open surgical modalities shape device selection preferences and influence healthcare provider training and integration into clinical workflows.
  • Clinical Indications: Devices are adopted in treating acute myocardial infarction, arrhythmias, heart failure, myocardial ischemia, and valvular disease, prompting segmentation according to the specific therapeutic pathway addressed.
  • End-User Channels: Hospitals, ambulatory surgical centers, and specialty clinics serve as primary markets, defining pathways for procurement and post-procedure patient management.
  • Regional Coverage: Americas, Europe Middle East & Africa, and Asia-Pacific—all characterized by different regulatory standards, reimbursement processes, and adoption rates—present unique challenges and opportunities for market participants.

Key Takeaways

  • Material innovation, advanced procedural planning, and miniaturized devices are increasingly central in supporting favorable patient outcomes and clinician workflows.
  • Healthcare institutions prioritize technologies that enable less invasive interventions and offer integration with real-time digital monitoring, driving interest in efficiency and actionable operational insights.
  • Manufacturers must address the entire ecosystem—clinical efficacy, supplier reliability, and strategic commercialization—highlighting the growing complexity of market operations and regulatory requirements.
  • Deepening segmentation across product, technology, and end-user categories intensifies the need for targeted clinical evidence and specialized training aligned with evolving clinician expectations.
  • Regional variations in reimbursement, procurement strategies, and research infrastructure directly affect how new products reach the market and gain competitive traction.

Tariff Impact on Supply Chains and Procurement

Tariff modifications introduced in 2025 caused notable shifts in supply chain design and procurement planning across the cardiovascular implants sector. In response to cost pressures on imported components, manufacturers diversified suppliers and increased nearshoring efforts, resulting in longer lead times and more involved contract negotiations. Smaller innovators, in particular, faced operational complexities as the industry moved toward vertical integration, updated inventory regimes, and stricter focus on supplier resilience. This shift has underscored the necessity of adaptable governance, flexible commercial agreements, and proactive scenario assessments in strategy development.

Methodology & Data Sources

A multi-method approach underpins the analysis in this report. Primary research was conducted via structured interviews with cardiovascular surgeons, interventional cardiologists, procurement executives, and leading manufacturers. Secondary resources, including regulatory reviews, patent assessments, and technical documentation, supplemented these insights. Data verification was achieved through robust triangulation, ensuring a high standard of reliability and relevance.

Why This Report Matters

  • Equips leadership with strategic benchmarks and current trends shaping the clinical, regulatory, and supply chain landscapes within the cardiovascular implants market.
  • Provides detailed segmentation insights, empowering targeted R&D, product innovation, and informed market-entry decisions suited to varying regional landscapes.
  • Supports forward-looking scenario planning by integrating technological, operational, and policy perspectives to aid both established market leaders and emerging players.

Conclusion

Market transformation in cardiovascular implants demands strategic alignment between clinical value creation, agile supply chain management, and effective regulatory interaction. Organizations poised to integrate these elements will better anticipate market evolution and unlock new growth opportunities in the sector.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Cardiovascular Implants Market, by Product Type
8.1. Heart Valves
8.1.1. Mechanical
8.1.2. Tissue
8.1.2.1. Bovine
8.1.2.2. Equine
8.1.2.3. Porcine
8.2. Implantable Cardioverter Defibrillators
8.2.1. Dual Chamber
8.2.2. Single Chamber
8.3. Occluders
8.3.1. Atrial Septal Defect
8.3.2. Patent Foramen Ovale
8.4. Pacemakers
8.4.1. Biventricular
8.4.2. Dual Chamber
8.4.3. Single Chamber
8.5. Stents
8.5.1. Bare Metal
8.5.2. Drug Eluting
8.5.2.1. Paclitaxel
8.5.2.2. Sirolimus
8.6. Vascular Grafts
8.6.1. Biological
8.6.1.1. Allograft
8.6.1.2. Autograft
8.6.1.3. Xenograft
8.6.2. Synthetic
9. Cardiovascular Implants Market, by Material
9.1. Biological Tissue
9.2. Metal
9.3. Polymer
10. Cardiovascular Implants Market, by Technology
10.1. Bare Metal
10.2. Bioabsorbable
10.3. Drug Eluting
11. Cardiovascular Implants Market, by Approach
11.1. Minimally Invasive
11.2. Open Surgical
12. Cardiovascular Implants Market, by Application
12.1. Acute Myocardial Infarction
12.2. Arrhythmias
12.3. Heart Failure
12.4. Myocardial Ischemia
12.5. Valvular Heart Disease
13. Cardiovascular Implants Market, by End-User
13.1. Ambulatory Surgical Centers
13.2. Hospitals
13.3. Specialty Clinics
14. Cardiovascular Implants Market, by Region
14.1. Americas
14.1.1. North America
14.1.2. Latin America
14.2. Europe, Middle East & Africa
14.2.1. Europe
14.2.2. Middle East
14.2.3. Africa
14.3. Asia-Pacific
15. Cardiovascular Implants Market, by Group
15.1. ASEAN
15.2. GCC
15.3. European Union
15.4. BRICS
15.5. G7
15.6. NATO
16. Cardiovascular Implants Market, by Country
16.1. United States
16.2. Canada
16.3. Mexico
16.4. Brazil
16.5. United Kingdom
16.6. Germany
16.7. France
16.8. Russia
16.9. Italy
16.10. Spain
16.11. China
16.12. India
16.13. Japan
16.14. Australia
16.15. South Korea
17. United States Cardiovascular Implants Market
18. China Cardiovascular Implants Market
19. Competitive Landscape
19.1. Market Concentration Analysis, 2025
19.1.1. Concentration Ratio (CR)
19.1.2. Herfindahl Hirschman Index (HHI)
19.2. Recent Developments & Impact Analysis, 2025
19.3. Product Portfolio Analysis, 2025
19.4. Benchmarking Analysis, 2025
19.5. Abbott Laboratories
19.6. Asahi Kasei Corporation
19.7. B. Braun Melsungen AG
19.8. BIOTRONIK
19.9. Boston Scientific Corporation
19.10. Cardinal Health
19.11. Edwards Lifesciences
19.12. Getinge
19.13. Impulse Dynamics
19.14. Johnson & Johnson
19.15. Lepu Medical Technology
19.16. LivaNova PLC
19.17. Medtronic
19.18. Meril Life Sciences
19.19. MicroPort Scientific Corporation
19.20. Sahajanand Medical Technologies (SMT)
19.21. Stryker
19.22. Terumo Corporation
19.23. Translumina Therapeutics
19.24. W. L. Gore & Associates
List of Figures
FIGURE 1. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL CARDIOVASCULAR IMPLANTS MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY MATERIAL, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY APPROACH, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY END-USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 13. UNITED STATES CARDIOVASCULAR IMPLANTS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 14. CHINA CARDIOVASCULAR IMPLANTS MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY HEART VALVES, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY HEART VALVES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY HEART VALVES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY HEART VALVES, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY MECHANICAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY MECHANICAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY MECHANICAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY TISSUE, BY REGION, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY TISSUE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY TISSUE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY TISSUE, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY BOVINE, BY REGION, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY BOVINE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY BOVINE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY EQUINE, BY REGION, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY EQUINE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY EQUINE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY PORCINE, BY REGION, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY PORCINE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY PORCINE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, BY REGION, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY DUAL CHAMBER, BY REGION, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY DUAL CHAMBER, BY GROUP, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY DUAL CHAMBER, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY SINGLE CHAMBER, BY REGION, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY SINGLE CHAMBER, BY GROUP, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY SINGLE CHAMBER, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY OCCLUDERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY OCCLUDERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY OCCLUDERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY OCCLUDERS, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY ATRIAL SEPTAL DEFECT, BY REGION, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY ATRIAL SEPTAL DEFECT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY ATRIAL SEPTAL DEFECT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY PATENT FORAMEN OVALE, BY REGION, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY PATENT FORAMEN OVALE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY PATENT FORAMEN OVALE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY PACEMAKERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY PACEMAKERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY PACEMAKERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY PACEMAKERS, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY BIVENTRICULAR, BY REGION, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY BIVENTRICULAR, BY GROUP, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY BIVENTRICULAR, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY DUAL CHAMBER, BY REGION, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY DUAL CHAMBER, BY GROUP, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY DUAL CHAMBER, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY SINGLE CHAMBER, BY REGION, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY SINGLE CHAMBER, BY GROUP, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY SINGLE CHAMBER, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY STENTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY STENTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY STENTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY STENTS, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY BARE METAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY BARE METAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY BARE METAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY DRUG ELUTING, BY REGION, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY DRUG ELUTING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY DRUG ELUTING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY DRUG ELUTING, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY PACLITAXEL, BY REGION, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY PACLITAXEL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY PACLITAXEL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY SIROLIMUS, BY REGION, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY SIROLIMUS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY SIROLIMUS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY VASCULAR GRAFTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY VASCULAR GRAFTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY VASCULAR GRAFTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 76. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY VASCULAR GRAFTS, 2018-2032 (USD MILLION)
TABLE 77. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY BIOLOGICAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 78. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY BIOLOGICAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 79. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY BIOLOGICAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 80. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY BIOLOGICAL, 2018-2032 (USD MILLION)
TABLE 81. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY ALLOGRAFT, BY REGION, 2018-2032 (USD MILLION)
TABLE 82. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY ALLOGRAFT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 83. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY ALLOGRAFT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 84. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY AUTOGRAFT, BY REGION, 2018-2032 (USD MILLION)
TABLE 85. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY AUTOGRAFT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 86. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY AUTOGRAFT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 87. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY XENOGRAFT, BY REGION, 2018-2032 (USD MILLION)
TABLE 88. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY XENOGRAFT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 89. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY XENOGRAFT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 90. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY SYNTHETIC, BY REGION, 2018-2032 (USD MILLION)
TABLE 91. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY SYNTHETIC, BY GROUP, 2018-2032 (USD MILLION)
TABLE 92. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY SYNTHETIC, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 93. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
TABLE 94. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY BIOLOGICAL TISSUE, BY REGION, 2018-2032 (USD MILLION)
TABLE 95. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY BIOLOGICAL TISSUE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 96. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY BIOLOGICAL TISSUE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 97. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY METAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 98. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY METAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 99. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY METAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 100. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY POLYMER, BY REGION, 2018-2032 (USD MILLION)
TABLE 101. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY POLYMER, BY GROUP, 2018-2032 (USD MILLION)
TABLE 102. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY POLYMER, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 103. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 104. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY BARE METAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 105. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY BARE METAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 106. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY BARE METAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 107. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY BIOABSORBABLE, BY REGION, 2018-2032 (USD MILLION)
TABLE 108. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY BIOABSORBABLE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 109. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY BIOABSORBABLE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 110. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY DRUG ELUTING, BY REGION, 2018-2032 (USD MILLION)
TABLE 111. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY DRUG ELUTING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 112. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY DRUG ELUTING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 113. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY APPROACH, 2018-2032 (USD MILLION)
TABLE 114. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY MINIMALLY INVASIVE, BY REGION, 2018-2032 (USD MILLION)
TABLE 115. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY MINIMALLY INVASIVE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 116. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY MINIMALLY INVASIVE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 117. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY OPEN SURGICAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 118. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY OPEN SURGICAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 119. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY OPEN SURGICAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 120. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 121. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY ACUTE MYOCARDIAL INFARCTION, BY REGION, 2018-2032 (USD MILLION)
TABLE 122. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY ACUTE MYOCARDIAL INFARCTION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 123. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY ACUTE MYOCARDIAL INFARCTION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 124. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY ARRHYTHMIAS, BY REGION, 2018-2032 (USD MILLION)
TABLE 125. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY ARRHYTHMIAS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 126. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY ARRHYTHMIAS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 127. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY HEART FAILURE, BY REGION, 2018-2032 (USD MILLION)
TABLE 128. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY HEART FAILURE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 129. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY HEART FAILURE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 130. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY MYOCARDIAL ISCHEMIA, BY REGION, 2018-2032 (USD MILLION)
TABLE 131. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY MYOCARDIAL ISCHEMIA, BY GROUP, 2018-2032 (USD MILLION)
TABLE 132. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY MYOCARDIAL ISCHEMIA, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 133. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY VALVULAR HEART DISEASE, BY REGION, 2018-2032 (USD MILLION)
TABLE 134. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY VALVULAR HEART DISEASE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 135. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY VALVULAR HEART DISEASE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 136. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 137. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 138. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 139. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 140. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 141. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 142. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 143. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 144. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY SPECIALTY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 145. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY SPECIALTY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 146. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 147. AMERICAS CARDIOVASCULAR IMPLANTS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 148. AMERICAS CARDIOVASCULAR IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 149. AMERICAS CARDIOVASCULAR IMPLANTS MARKET SIZE, BY HEART VALVES, 2018-2032 (USD MILLION)
TABLE 150. AMERICAS CARDIOVASCULAR IMPLANTS MARKET SIZE, BY TISSUE, 2018-2032 (USD MILLION)
TABLE 151. AMERICAS CARDIOVASCULAR IMPLANTS MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2032 (USD MILLION)
TABLE 152. AMERICAS CARDIOVASCULAR IMPLANTS MARKET SIZE, BY OCCLUDERS, 2018-2032 (USD MILLION)
TABLE 153. AMERICAS CARDIOVASCULAR IMPLANTS MARKET SIZE, BY PACEMAKERS, 2018-2032 (USD MILLION)
TABLE 154. AMERICAS CARDIOVASCULAR IMPLANTS MARKET SIZE, BY STENTS, 2018-2032 (USD MILLION)
TABLE 155. AMERICAS CARDIOVASCULAR IMPLANTS MARKET SIZE, BY DRUG ELUTING, 2018-2032 (USD MILLION)
TABLE 156. AMERICAS CARDIOVASCULAR IMPLANTS MARKET SIZE, BY VASCULAR GRAFTS, 2018-2032 (USD MILLION)
TABLE 157. AMERICAS CARDIOVASCULAR IMPLANTS MARKET SIZE, BY BIOLOGICAL, 2018-2032 (USD MILLION)
TABLE 158. AMERICAS CARDIOVASCULAR IMPLANTS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
TABLE 159. AMERICAS CARDIOVASCULAR IMPLANTS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 160. AMERICAS CARDIOVASCULAR IMPLANTS MARKET SIZE, BY APPROACH, 2018-2032 (USD MILLION)
TABLE 161. AMERICAS CARDIOVASCULAR IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 162. AMERICAS CARDIOVASCULAR IMPLANTS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 163. NORTH AMERICA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 164. NORTH AMERICA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 165. NORTH AMERICA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY HEART VALVES, 2018-2032 (USD MILLION)
TABLE 166. NORTH AMERICA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY TISSUE, 2018-2032 (USD MILLION)
TABLE 167. NORTH AMERICA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2032 (USD MILLION)
TABLE 168. NORTH AMERICA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY OCCLUDERS, 2018-2032 (USD MILLION)
TABLE 169. NORTH AMERICA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY PACEMAKERS, 2018-2032 (USD MILLION)
TABLE 170. NORTH AMERICA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY STENTS, 2018-2032 (USD MILLION)
TABLE 171. NORTH AMERICA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY DRUG ELUTING, 2018-2032 (USD MILLION)
TABLE 172. NORTH AMERICA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY VASCULAR GRAFTS, 2018-2032 (USD MILLION)
TABLE 173. NORTH AMERICA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY BIOLOGICAL, 2018-2032 (USD MILLION)
TABLE 174. NORTH AMERICA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
TABLE 175. NORTH AMERICA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 176. NORTH AMERICA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY APPROACH, 2018-2032 (USD MILLION)
TABLE 177. NORTH AMERICA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 178. NORTH AMERICA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 179. LATIN AMERICA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 180. LATIN AMERICA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 181. LATIN AMERICA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY HEART VALVES, 2018-2032 (USD MILLION)
TABLE 182. LATIN AMERICA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY TISSUE, 2018-2032 (USD MILLION)
TABLE 183. LATIN AMERICA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2032 (USD MILLION)
TABLE 184. LATIN AMERICA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY OCCLUDERS, 2018-2032 (USD MILLION)
TABLE 185. LATIN AMERICA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY PACEMAKERS, 2018-2032 (USD MILLION)
TABLE 186. LATIN AMERICA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY STENTS, 2018-2032 (USD MILLION)
TABLE 187. LATIN AMERICA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY DRUG ELUTING, 2018-2032 (USD MILLION)
TABLE 188. LATIN AMERICA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY VASCULAR GRAFTS, 2018-2032 (USD MILLION)
TABLE 189. LATIN AMERICA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY BIOLOGICAL, 2018-2032 (USD MILLION)
TABLE 190. LATIN AMERICA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
TABLE 191. LATIN AMERICA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 192. LATIN AMERICA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY APPROACH, 2018-2032 (USD MILLION)
TABLE 193. LATIN AMERICA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 194. LATIN AMERICA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 195. EUROPE, MIDDLE EAST & AFRICA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 196. EUROPE, MIDDLE EAST & AFRICA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 197. EUROPE, MIDDLE EAST & AFRICA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY HEART VALVES, 2018-2032 (USD MILLION)
TABLE 198. EUROPE, MIDDLE EAST & AFRICA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY TISSUE, 2018-2032 (USD MILLION)
TABLE 199. EUROPE, MIDDLE EAST & AFRICA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2032 (USD MILLION)
TABLE 200. EUROPE, MIDDLE EAST & AFRICA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY OCCLUDERS, 2018-2032 (USD MILLION)
TABLE 201. EUROPE, MIDDLE EAST & AFRICA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY PACEMAKERS, 2018-2032 (USD MILLION)
TABLE 202. EUROPE, MIDDLE EAST & AFRICA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY STENTS, 2018-2032 (USD MILLION)
TABLE 203. EUROPE, MIDDLE EAST & AFRICA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY DRUG ELUTING, 2018-2032 (USD MILLION)
TABLE 204. EUROPE, MIDDLE EAST & AFRICA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY VASCULAR GRAFTS, 2018-2032 (USD MILLION)
TABLE 205. EUROPE, MIDDLE EAST & AFRICA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY BIOLOGICAL, 2018-2032 (USD MILLION)
TABLE 206. EUROPE, MIDDLE EAST & AFRICA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
TABLE 207. EUROPE, MIDDLE EAST & AFRICA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 208. EUROPE, MIDDLE EAST & AFRICA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY APPROACH, 2018-2032 (USD MILLION)
TABLE 209. EUROPE, MIDDLE EAST & AFRICA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 210. EUROPE, MIDDLE EAST & AFRICA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 211. EUROPE CARDIOVASCULAR IMPLANTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 212. EUROPE CARDIOVASCULAR IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 213. EUROPE CARDIOVASCULAR IMPLANTS MARKET SIZE, BY HEART VALVES, 2018-2032 (USD MILLION)
TABLE 214. EUROPE CARDIOVASCULAR IMPLANTS MARKET SIZE, BY TISSUE, 2018-2032 (USD MILLION)
TABLE 215. EUROPE CARDIOVASCULAR IMPLANTS MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2032 (USD MILLION)
TABLE 216. EUROPE CARDIOVASCULAR IMPLANTS MARKET SIZE, BY OCCLUDERS, 2018-2032 (USD MILLION)
TABLE 217. EUROPE CARDIOVASCULAR IMPLANTS MARKET SIZE, BY PACEMAKERS, 2018-2032 (USD MILLION)
TABLE 218. EUROPE CARDIOVASCULAR IMPLANTS MARKET SIZE, BY STENTS, 2018-2032 (USD MILLION)
TABLE 219. EUROPE CARDIOVASCULAR IMPLANTS MARKET SIZE, BY DRUG ELUTING, 2018-2032 (USD MILLION)
TABLE 220. EUROPE CARDIOVASCULAR IMPLANTS MARKET SIZE, BY VASCULAR GRAFTS, 2018-2032 (USD MILLION)
TABLE 221. EUROPE CARDIOVASCULAR IMPLANTS MARKET SIZE, BY BIOLOGICAL, 2018-2032 (USD MILLION)
TABLE 222. EUROPE CARDIOVASCULAR IMPLANTS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
TABLE 223. EUROPE CARDIOVASCULAR IMPLANTS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 224. EUROPE CARDIOVASCULAR IMPLANTS MARKET SIZE, BY APPROACH, 2018-2032 (USD MILLION)
TABLE 225. EUROPE CARDIOVASCULAR IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 226. EUROPE CARDIOVASCULAR IMPLANTS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 227. MIDDLE EAST CARDIOVASCULAR IMPLANTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 228. MIDDLE EAST CARDIOVASCULAR IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 229. MIDDLE EAST CARDIOVASCULAR IMPLANTS MARKET SIZE, BY HEART VALVES, 2018-2032 (USD MILLION)
TABLE 230. MIDDLE EAST CARDIOVASCULAR IMPLANTS MARKET SIZE, BY TISSUE, 2018-2032 (USD MILLION)
TABLE 231. MIDDLE EAST CARDIOVASCULAR IMPLANTS MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2032 (USD MILLION)
TABLE 232. MIDDLE EAST CARDIOVASCULAR IMPLANTS MARKET SIZE, BY OCCLUDERS, 2018-2032 (USD MILLION)
TABLE 233. MIDDLE EAST CARDIOVASCULAR IMPLANTS MARKET SIZE, BY PACEMAKERS, 2018-2032 (USD MILLION)
TABLE 234. MIDDLE EAST CARDIOVASCULAR IMPLANTS MARKET SIZE, BY STENTS, 2018-2032 (USD MILLION)
TABLE 235. MIDDLE EAST CARDIOVASCULAR IMPLANTS MARKET SIZE, BY DRUG ELUTING, 2018-2032 (USD MILLION)
TABLE 236. MIDDLE EAST CARDIOVASCULAR IMPLANTS MARKET SIZE, BY VASCULAR GRAFTS, 2018-2032 (USD MILLION)
TABLE 237. MIDDLE EAST CARDIOVASCULAR IMPLANTS MARKET SIZE, BY BIOLOGICAL, 2018-2032 (USD MILLION)
TABLE 238. MIDDLE EAST CARDIOVASCULAR IMPLANTS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
TABLE 239. MIDDLE EAST CARDIOVASCULAR IMPLANTS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 240. MIDDLE EAST CARDIOVASCULAR IMPLANTS MARKET SIZE, BY APPROACH, 2018-2032 (USD MILLION)
TABLE 241. MIDDLE EAST CARDIOVASCULAR IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 242. MIDDLE EAST CARDIOVASCULAR IMPLANTS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 243. AFRICA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 244. AFRICA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 245. AFRICA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY HEART VALVES, 2018-2032 (USD MILLION)
TABLE 246. AFRICA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY TISSUE, 2018-2032 (USD MILLION)
TABLE 247. AFRICA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2032 (USD MILLION)
TABLE 248. AFRICA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY OCCLUDERS, 2018-2032 (USD MILLION)
TABLE 249. AFRICA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY PACEMAKERS, 2018-2032 (USD MILLION)
TABLE 250. AFRICA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY STENTS, 2018-2032 (USD MILLION)
TABLE 251. AFRICA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY DRUG ELUTING, 2018-2032 (USD MILLION)
TABLE 252. AFRICA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY VASCULAR GRAFTS, 2018-2032 (USD MILLION)
TABLE 253. AFRICA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY BIOLOGICAL, 2018-2032 (USD MILLION)
TABLE 254. AFRICA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
TABLE 255. AFRICA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 256. AFRICA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY APPROACH, 2018-2032 (USD MILLION)
TABLE 257. AFRICA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 258. AFRICA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 259. ASIA-PACIFIC CARDIOVASCULAR IMPLANTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 260. ASIA-PACIFIC CARDIOVASCULAR IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 261. ASIA-PACIFIC CARDIOVASCULAR IMPLANTS MARKET SIZE, BY HEART VALVES, 2018-2032 (USD MILLION)
TABLE 262. ASIA-PACIFIC CARDIOVASCULAR IMPLANTS MARKET SIZE, BY TISSUE, 2018-2032 (USD MILLION)
TABLE 263. ASIA-PACIFIC CARDIOVASCULAR IMPLANTS MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2032 (USD MILLION)
TABLE 264. ASIA-PACIFIC CARDIOVASCULAR IMPLANTS MARKET SIZE, BY OCCLUDERS, 2018-2032 (USD MILLION)
TABLE 265. ASIA-PACIFIC CARDIOVASCULAR IMPLANTS MARKET SIZE, BY PACEMAKERS, 2018-2032 (USD MILLION)
TABLE 266. ASIA-PACIFIC CARDIOVASCULAR IMPLANTS MARKET SIZE, BY STENTS, 2018-2032 (USD MILLION)
TABLE 267. ASIA-PACIFIC CARDIOVASCULAR IMPLANTS MARKET SIZE, BY DRUG ELUTING, 2018-2032 (USD MILLION)
TABLE 268. ASIA-PACIFIC CARDIOVASCULAR IMPLANTS MARKET SIZE, BY VASCULAR GRAFTS, 2018-2032 (USD MILLION)
TABLE 269. ASIA-PACIFIC CARDIOVASCULAR IMPLANTS MARKET SIZE, BY BIOLOGICAL, 2018-2032 (USD MILLION)
TABLE 270. ASIA-PACIFIC CARDIOVASCULAR IMPLANTS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
TABLE 271. ASIA-PACIFIC CARDIOVASCULAR IMPLANTS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 272. ASIA-PACIFIC CARDIOVASCULAR IMPLANTS MARKET SIZE, BY APPROACH, 2018-2032 (USD MILLION)
TABLE 273. ASIA-PACIFIC CARDIOVASCULAR IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 274. ASIA-PACIFIC CARDIOVASCULAR IMPLANTS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 275. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 276. ASEAN CARDIOVASCULAR IMPLANTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 277. ASEAN CARDIOVASCULAR IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 278. ASEAN CARDIOVASCULAR IMPLANTS MARKET SIZE, BY HEART VALVES, 2018-2032 (USD MILLION)
TABLE 279. ASEAN CARDIOVASCULAR IMPLANTS MARKET SIZE, BY TISSUE, 2018-2032 (USD MILLION)
TABLE 280. ASEAN CARDIOVASCULAR IMPLANTS MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2032 (USD MILLION)
TABLE 281. ASEAN CARDIOVASCULAR IMPLANTS MARKET SIZE, BY OCCLUDERS, 2018-2032 (USD MILLION)
TABLE 282. ASEAN CARDIOVASCULAR IMPLANTS MARKET SIZE, BY PACEMAKERS, 2018-2032 (USD MILLION)
TABLE 283. ASEAN CARDIOVASCULAR IMPLANTS MARKET SIZE, BY STENTS, 2018-2032 (USD MILLION)
TABLE 284. ASEAN CARDIOVASCULAR IMPLANTS MARKET SIZE, BY DRUG ELUTING, 2018-2032 (USD MILLION)
TABLE 285. ASEAN CARDIOVASCULAR IMPLANTS MARKET SIZE, BY VASCULAR GRAFTS, 2018-2032 (USD MILLION)
TABLE 286. ASEAN CARDIOVASCULAR IMPLANTS MARKET SIZE, BY BIOLOGICAL, 2018-2032 (USD MILLION)
TABLE 287. ASEAN CARDIOVASCULAR IMPLANTS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
TABLE 288. ASEAN CARDIOVASCULAR IMPLANTS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 289. ASEAN CARDIOVASCULAR IMPLANTS MARKET SIZE, BY APPROACH, 2018-2032 (USD MILLION)
TABLE 290. ASEAN CARDIOVASCULAR IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 291. ASEAN CARDIOVASCULAR IMPLANTS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 292. GCC CARDIOVASCULAR IMPLANTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 293. GCC CARDIOVASCULAR IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 294. GCC CARDIOVASCULAR IMPLANTS MARKET SIZE, BY HEART VALVES, 2018-2032 (USD MILLION)
TABLE 295. GCC CARDIOVASCULAR IMPLANTS MARKET SIZE, BY TISSUE, 2018-2032 (USD MILLION)
TABLE 296. GCC CARDIOVASCULAR IMPLANTS MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2032 (USD MILLION)
TABLE 297. GCC CARDIOVASCULAR IMPLANTS MARKET SIZE, BY OCCLUDERS, 2018-2032 (USD MILLION)
TABLE 298. GCC CARDIOVASCULAR IMPLANTS MARKET SIZE, BY PACEMAKERS, 2018-2032 (USD MILLION)
TABLE 299. GCC CARDIOVASCULAR IMPLANTS MARKET SIZE, BY STENTS, 2018-2032 (USD MILLION)
TABLE 300. GCC CARDIOVASCULAR IMPLANTS MARKET SIZE, BY DRUG ELUTING, 2018-2032 (USD MILLION)
TABLE 301. GCC CARDIOVASCULAR IMPLANTS MARKET SIZE, BY VASCULAR GRAFTS, 2018-2032 (USD MILLION)
TABLE 302. GCC CARDIOVASCULAR IMPLANTS MARKET SIZE, BY BIOLOGICAL, 2018-2032 (USD MILLION)
TABLE 303. GCC CARDIOVASCULAR IMPLANTS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
TABLE 304. GCC CARDIOVASCULAR IMPLANTS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 305. GCC CARDIOVASCULAR IMPLANTS MARKET SIZE, BY APPROACH, 2018-2032 (USD MILLION)
TABLE 306. GCC CARDIOVASCULAR IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 307. GCC CARDIOVASCULAR IMPLANTS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 308. EUROPEAN UNION CARDIOVASCULAR IMPLANTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 309. EUROPEAN UNION CARDIOVASCULAR IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 310. EUROPEAN UNION CARDIOVASCULAR IMPLANTS MARKET SIZE, BY HEART VALVES, 2018-2032 (USD MILLION)
TABLE 311. EUROPEAN UNION CARDIOVASCULAR IMPLANTS MARKET SIZE, BY TISSUE, 2018-2032 (USD MILLION)
TABLE 312. EUROPEAN UNION CARDIOVASCULAR IMPLANTS MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2032 (USD MILLION)
TABLE 313. EUROPEAN UNION CARDIOVASCULAR IMPLANTS MARKET SIZE, BY OCCLUDERS, 2018-2032 (USD MILLION)
TABLE 314. EUROPEAN UNION CARDIOVASCULAR IMPLANTS MARKET SIZE, BY PACEMAKERS, 2018-2032 (USD MILLION)
TABLE 315. EUROPEAN UNION CARDIOVASCULAR IMPLANTS MARKET SIZE, BY STENTS, 2018-2032 (USD MILLION)
TABLE 316. EUROPEAN UNION CARDIOVASCULAR IMPLANTS MARKET SIZE, BY DRUG ELUTING, 2018-2032 (USD MILLION)
TABLE 317. EUROPEAN UNION CARDIOVASCULAR IMPLANTS MARKET SIZE, BY VASCULAR GRAFTS, 2018-2032 (USD MILLION)
TABLE 318. EUROPEAN UNION CARDIOVASCULAR IMPLANTS MARKET SIZE, BY BIOLOGICAL, 2018-2032 (USD MILLION)
TABLE 319. EUROPEAN UNION CARDIOVASCULAR IMPLANTS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
TABLE

Companies Mentioned

The key companies profiled in this Cardiovascular Implants market report include:
  • Abbott Laboratories
  • Asahi Kasei Corporation
  • B. Braun Melsungen AG
  • BIOTRONIK
  • Boston Scientific Corporation
  • Cardinal Health
  • Edwards Lifesciences
  • Getinge
  • Impulse Dynamics
  • Johnson & Johnson
  • Lepu Medical Technology
  • LivaNova PLC
  • Medtronic
  • Meril Life Sciences
  • MicroPort Scientific Corporation
  • Sahajanand Medical Technologies (SMT)
  • Stryker
  • Terumo Corporation
  • Translumina Therapeutics
  • W. L. Gore & Associates

Table Information

Report AttributeDetails
No. of Pages181
PublishedJanuary 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 39.78 Billion
Forecasted Market Value ( USD ) by 2032 $ 57.98 Billion
Compound Annual Growth Rate6.3%
Regions CoveredGlobal
No. of Companies Mentioned21

Related Topics

Related Reports

Cardiovascular Implants Market Report 2025 - Product Image

Cardiovascular Implants Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Cardiovascular Implants Market Report by Product Type, Material, Procedure Type, Indication, and Region 2025-2033 - Product Image

Cardiovascular Implants Market Report by Product Type, Material, Procedure Type, Indication, and Region 2025-2033

  • Report
  • 143 Pages
  • Global
From
Cardiovascular Implants - Global Strategic Business Report - Product Image

Cardiovascular Implants - Global Strategic Business Report

  • Report
  • 188 Pages
  • Global
From
Cardiovascular Implants Market Outlook 2025-2034: Market Share, and Growth Analysis - Product Image

Cardiovascular Implants Market Outlook 2025-2034: Market Share, and Growth Analysis

  • Report
  • 160 Pages
  • Global
From
Cardiovascular Repair & Reconstruction Devices Market - Global Forecast 2026-2032 - Product Image

Cardiovascular Repair & Reconstruction Devices Market - Global Forecast 2026-2032

  • Report
  • 181 Pages
  • Global
From

About the Cardiovascular Implant Market

The Cardiovascular Implant market is a subset of the Cardiovascular Devices market, which includes a wide range of products used to diagnose, treat, and monitor cardiovascular diseases. Cardiovascular Implants are medical devices that are surgically implanted into the body to treat cardiovascular diseases. These devices include pacemakers, implantable cardioverter defibrillators (ICDs), and ventricular assist devices (VADs). They are designed to regulate the heart rate, detect arrhythmias, and provide mechanical support to the heart. Cardiovascular Implants are used to treat a variety of cardiovascular diseases, including arrhythmias, heart failure, and coronary artery disease. They are also used to improve the quality of life of patients with cardiovascular diseases. Some of the major companies in the Cardiovascular Implant market include Medtronic, Abbott, Boston Scientific, St. Jude Medical, and Sorin Group. These companies are involved in the development, manufacturing, and marketing of cardiovascular implants. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.